Male-specific cardiac dysfunction in CTP:Phosphoethanolamine cytidylyltransferase (Pcyt2)-deficient mice

Molecular and Cellular Biology

Volumn 35, Issue 15, 2015, Pages 2641-2657

  Basu, Poulami ^a   Alibhai, Faisal J ^a   Tsimakouridze, Elena V ^a   Singh, Ratnesh K ^a   Paglialunga, Sabina ^a   Holloway, Graham P ^a   Martino, Tami A ^a   Bakovic, Marica ^a  

^a UNIVERSITY OF GUELPH   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ACTIN; ARACHIDONIC ACID; CD36 ANTIGEN; CYTIDINE TRIPHOSPHATE; FAT DROPLET; INSULIN; MESSENGER RNA; MYOSIN HEAVY CHAIN; MYOSIN HEAVY CHAIN 7; NATRIURETIC FACTOR; NATRIURETIC PEPTIDE TYPE A; PANCREAS POLYPEPTIDE; PHOSPHOETHANOLAMINE CYTIDYLYLTRANSFERASE 2; POLYUNSATURATED FATTY ACID; SOMATOSTATIN; UNCLASSIFIED DRUG; ACTIN; DIPEPTIDYL CARBOXYPEPTIDASE; ETHANOLAMINE-PHOSPHATE CYTIDYLYLTRANSFERASE; FATTY ACID; GLUCOSE; GLUCOSE TRANSPORTER 4; MYH7 PROTEIN, MOUSE; PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLINOSITOL 3 KINASE; REACTIVE OXYGEN METABOLITE; RNA POLYMERASE; SLC2A4 PROTEIN, MOUSE;

ABDOMINAL OBESITY; ADULT; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL SIZE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; GENE EXPRESSION REGULATION; HEART MUSCLE CELL; HEART VENTRICLE HYPERTROPHY; HYPERTENSION; HYPERTRIGLYCERIDEMIA; INSULIN RESISTANCE; LIPID COMPOSITION; LIPID HOMEOSTASIS; LIPID PEROXIDATION; LIPOGENESIS; LIVER MITOCHONDRION; MALE; MEAN ARTERIAL PRESSURE; MOUSE; MULTIPLE ORGAN FAILURE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; UPREGULATION; WILD TYPE MOUSE; ANIMAL; AORTA; BIOSYNTHESIS; CARDIOMEGALY; GENETICS; HEART; HYPERLIPIDEMIA; METABOLISM; OBESITY; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE;

MUS;

ACTINS; ANIMALS; ANTIGENS, CD36; AORTA; ARACHIDONIC ACID; CARDIOMEGALY; FATTY ACIDS; FEMALE; GLUCOSE; GLUCOSE TRANSPORTER TYPE 4; HEART; HYPERLIPIDEMIAS; HYPERTENSION; INSULIN RESISTANCE; LIPID PEROXIDATION; MALE; MICE; MICE, TRANSGENIC; MYOSIN HEAVY CHAINS; OBESITY; PEPTIDYL-DIPEPTIDASE A; PHOSPHATIDYLETHANOLAMINES; PHOSPHATIDYLINOSITOL 3-KINASE; REACTIVE OXYGEN SPECIES; RNA NUCLEOTIDYLTRANSFERASES; SEX FACTORS; SIGNAL TRANSDUCTION;

EID: 84936138347     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.00380-15     Document Type: Article

References (41)

1. Kolwicz SC, Jr, Purohit S, Tian R. 2013. Cardiac metabolism and its interactions with contraction, growth, and survival of cardiomyocytes. Circ Res 113:603-616. http://dx.doi.org/10.1161/CIRCRESAHA.113.302095.
2. Neely JR, Morgan HE. 1974. Relationship between carbohydrate and lipid metabolism and the energy balance of heart muscle. Annu Rev Physiol 36: 413-459. http://dx.doi.org/10.1146/annurev.ph.36.030174.002213.
3. Lopaschuk GD, Ussher JR, Folmes CD, Jaswal JS, Stanley WC. 2010. Myocardial fatty acid metabolism in health and disease. Physiol Rev 90: 207-258. http://dx.doi.org/10.1152/physrev.00015.2009.
4. Bakovic M, Fullerton MD, Michel V. 2007. Metabolic and molecular aspects of ethanolamine phospholipid biosynthesis: the role of CTP: phosphoethanolamine cytidylyltransferase (Pcyt2). Biochem Cell Biol 85: 283-300. http://dx.doi.org/10.1139/O07-006.
5. Poloumienko A, Cote A, Quee AT, Zhu L, Bakovic M. 2004. Genomic organization and differential splicing of the mouse and human Pcyt2 genes. Gene 325:145-155. http://dx.doi.org/10.1016/j.gene.2003.10.005.
6. Min-Seok R, Kawamata Y, Nakamura H, Ohta A, Takagi M. 1996. Isolation and characterization of ECT1 gene encoding CTP: phosphoethanolamine cytidylyltransferase of Saccharomyces cerevisiae. J Biochem 120:1040-1047. http://dx.doi.org/10.1093/oxfordjournals.jbchem.a021497.
7. Bladergroen BA, Houweling M, Geelen MJ, van Golde LM. 1999. Cloning and expression of CTP:phosphoethanolamine cytidylyltransferase cDNA from rat liver. Biochem J 343(Part 1):107-114.
8. Tie A, Bakovic M. 2007. Alternative splicing of CTP:phosphoethanolamine cytidylyltransferase produces two isoforms that differ in catalytic properties. J Lipid Res 48:2172-2181. http://dx.doi.org/10.1194/jlr.M600536-JLR200.
9. Fullerton MD, Hakimuddin F, Bakovic M. 2007. Developmental and metabolic effects of disruption of the mouse CTP:phosphoethanolamine cytidylyltransferase gene (Pcyt2). Mol Cell Biol 27:3327-3336. http://dx.doi.org/10.1128/MCB.01527-06.
10. Mizoi J, Nakamura M, Nishida I. 2006. Defects in CTP:phosphoryl ethanolamine affect embryonic and postembryonic development in Arabidopsis. Plant Cell 18:3370-3385. http://dx.doi.org/10.1105/tpc.106.040840.
11. Fullerton MD, Hakimuddin F, Bonen A, Bakovic M. 2009. The development of a metabolic disease phenotype in CTP:phosphoethanolamine cytidylyltransferase-deficient mice. J Biol Chem 284:25704-25713. http://dx.doi.org/10.1074/jbc.M109.023846.
12. Leonardi R, Frank MW, Jackson PD, Rock CO, Jackowski S. 2009. Elimination of the CDP-ethanolamine pathway disrupts hepatic lipid homeostasis. J Biol Chem 284:27077-27089. http://dx.doi.org/10.1074/jbc.M109.031336.
13. Khan RS, Drosatos K, Goldberg IJ. 2010. Creating and curing fatty hearts. Curr Opin Clin Nutr Metab Care 13:145-149. http://dx.doi.org/10.1097/MCO.0b013e3283357272.
14. Lim HY, Bodmer R. 2011. Phospholipid homeostasis and lipotoxic cardiomyopathy: a matter of balance. Fly (Austin) 5:234-236. http://dx.doi.org/10.4161/fly.5.3.15708.
15. Lim HY, Wang W, Wessells RJ, Ocorr K, Bodmer R. 2011. Phospholipid homeostasis regulates lipid metabolism and cardiac function through SREBP signaling in Drosophila. Genes Dev 25:189-200. http://dx.doi.org/10.1101/gad.1992411.
16. Holloway GP, Snook LA, Harris RJ, Glatz JF, Luiken JJ, Bonen A. 2011. In obese Zucker rats, lipids accumulate in the heart despite normal mitochondrial content, morphology and long-chain fatty acid oxidation. J Physiol 589:169-180. http://dx.doi.org/10.1113/jphysiol.2010.198663.
17. Ku SK, Lee HS, Lee JH. 2002. An immunohistochemical study of pancreatic endocrine cells in SKH-1 hairless mice. Eur J Histochem 46:229-236.
18. Alibhai FJ, Tsimakouridze EV, Chinnappareddy N, Wright DC, Billia F, O'Sullivan ML, Pyle WG, Sole MJ, Martino TA. 2014. Short-term disruption of diurnal rhythms after murine myocardial infarction adversely affects long-term myocardial structure and function. Circ Res 114: 1713-1722. http://dx.doi.org/10.1161/CIRCRESAHA.114.302995.
19. Tsimakouridze EV, Straume M, Podobed PS, Chin H, LaMarre J, Johnson R, Antenos M, Kirby GM, Mackay A, Huether P, Simpson JA, Sole M, Gadal G, Martino TA. 2012. Chronomics of pressure overloadinduced cardiac hypertrophy in mice reveals altered day/night gene expression and biomarkers of heart disease. Chronobiol Int 29:810-821. http://dx.doi.org/10.3109/07420528.2012.691145.
20. Schenkel LC, Singh RK, Michel V, Zeisel SH, da Costa KA, Johnson AR, Mudd HS, Bakovic M. 2 December 2014. Mechanism of choline deficiency and membrane alteration in postural orthostatic tachycardia syndrome primary skin fibroblasts. FASEB J http://dx.doi.org/10.1096/fj.14-258566.
21. Bligh EG, Dyer WJ. 1959. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37:911-917. http://dx.doi.org/10.1139/o59-099.
22. Paul S, Grevengoed TJ, Pascual F, Ellis JM, Willis MS, Coleman RA. 2014. Deficiency of cardiac acylCoA synthetase 1 induces diastolic dysfunction, but pathologic hypertrophy is reversed by rapamycin. Biochim Biophys Acta 1841:880-887. http://dx.doi.org/10.1016/j.bbalip.2014.03.001.
23. Mosca L. 2004. Cardiology patient page. Heart disease prevention in women. American Heart Association. Circulation 109:e158-e160. http://dx.doi.org/10.1161/01.CIR.0000124449.48800.C3.
24. Frohlich ED, Apstein C, Chobanian AV, Devereux RB, Dustan HP, Dzau V, Fauad-Tarazi F, Horan MJ, Marcus M, Massie B, Pfeffer MA, Re RN, Roccella EJ, Savage D, Shub C. 1992. The heart in hypertension. N Engl J Med 327:998-1008. http://dx.doi.org/10.1056/NEJM199210013271406.
25. Sambandam N, Lopaschuk GD, Brownsey RW, Allard MF. 2002. Energy metabolism in the hypertrophied heart. Heart Fail Rev 7:161-173. http://dx.doi.org/10.1023/A:1015380609464.
26. Tappia PS, Singal T. 2008. Phospholipid-mediated signaling and heart disease. Subcell Biochem 49:299-324. http://dx.doi.org/10.1007/978-1-4020-8831-5_11.
27. Abel ED, O'Shea KM, Ramasamy R. 2012. Insulin resistance: metabolic mechanisms and consequences in the heart. Arterioscler Thromb Vasc Biol 32:2068-2076. http://dx.doi.org/10.1161/ATVBAHA.111.241984.
28. Sharma S, Adrogue JV, Golfman L, Uray I, Lemm J, Youker K, Noon GP, Frazier OH, Taegtmeyer H. 2004. Intramyocardial lipid accumulation in the failing human heart resembles the lipotoxic rat heart. FASEB J 18:1692-1700. http://dx.doi.org/10.1096/fj.04-2263com.
29. Ruberg FL. 2007. Myocardial lipid accumulation in the diabetic heart. Circulation 116:1110-1112. http://dx.doi.org/10.1161/CIRCULATIONAHA.107.721860.
30. Kienesberger PC, Pulinilkunnil T, Nagendran J, Dyck JR. 2013. Myocardial triacylglycerol metabolism. J Mol Cell Cardiol 55:101-110. http://dx.doi.org/10.1016/j.yjmcc.2012.06.018.
31. Febbraio M, Abumrad NA, Hajjar DP, Sharma K, Cheng W, Pearce SF, Silverstein RL. 1999. A null mutation in murine CD36 reveals an important role in fatty acid and lipoprotein metabolism. J Biol Chem 274:19055-19062. http://dx.doi.org/10.1074/jbc.274.27.19055.
32. Pietka TA, Sulkin MS, Kuda O, Wang W, Zhou D, Yamada KA, Yang K, Su X, Gross RW, Nerbonne JM, Efimov IR, Abumrad NA. 2012. CD36 protein influences myocardial Ca2+ homeostasis and phospholipid metabolism: conduction anomalies in CD36-deficient mice during fasting. J Biol Chem 287:38901-38912. http://dx.doi.org/10.1074/jbc.M112.413609.
33. Tanaka T, Sohmiya K, Kawamura K. 1997. Is CD36 deficiency an etiology of hereditary hypertrophic cardiomyopathy?. J Mol Cell Cardiol 29: 121-127. http://dx.doi.org/10.1006/jmcc.1996.0257.
34. Slater-Jefferies JL, Hoile SP, Lillycrop KA, Townsend PA, Hanson MA, Burdge GC. 2010. Effect of sex and dietary fat intake on the fatty acid composition of phospholipids and triacylglycerol in rat heart. Prostaglandins Leukot Essent Fatty Acids 83(4-6):219-223. http://dx.doi.org/10.1016/j.plefa.2010.07.006.
35. Crowe FL, Skeaff CM, Green TJ, Gray AR. 2008. Serum n-3 long-chain PUFA differ by sex and age in a population-based survey of New Zealand adolescents and adults. Br J Nutr 99:168-174. http://dx.doi.org/10.1017/S000711450779387X.
36. Burdge GC, Slater-Jefferies JL, Grant RA, Chung WS, West AL, Lillycrop KA. 2008. Sex, but not maternal protein or folic acid intake, determines the fatty acid composition of hepatic phospholipids, but not of triacylglycerol, in adult rats. Prostaglandins Leukot Essent Fatty Acids 78:73-79. http://dx.doi.org/10.1016/j.plefa.2007.10.028.
37. Decsi T, Kennedy K. 2011. Sex-specific differences in essential fatty acid metabolism. Am J Clin Nutr 94(6 Suppl):1914S-1919S. http://dx.doi.org/10.3945/ajcn.110.000893.
38. Burdge GC, Calder PC. 2006. Dietary alpha-linolenic acid and healthrelated outcomes: a metabolic perspective. Nutr Res Rev 19:26-52. http://dx.doi.org/10.1079/NRR2005113.
39. Jones TH. 2010. Testosterone deficiency: a risk factor for cardiovascular disease?. Trends Endocrinol Metab 21:496-503. http://dx.doi.org/10.1016/j.tem.2010.03.002.
40. Kaushik M, Sontineni SP, Hunter C. 2010. Cardiovascular disease and androgens: a review. Int J Cardiol 142:8-14. http://dx.doi.org/10.1016/j.ijcard.2009.10.033.
41. Traish AM, Kypreos KE. 2011. Testosterone and cardiovascular disease: an old idea with modern clinical implications. Atherosclerosis 214:244-248. http://dx.doi.org/10.1016/j.atherosclerosis.2010.08.078.